| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/27/2008 | CN100371346C Artificial synthesized insulin-simulated peptide and its application |
| 02/27/2008 | CN100371323C Cyanopyrrolidine derivatives |
| 02/27/2008 | CN100371018C Calcitonin composition |
| 02/27/2008 | CN100371001C Usage of rhubarb root and its extractions in the process for preparing postprandial blood sugar decreasing medicine |
| 02/27/2008 | CN100370996C Soft capsule of forest frogoil, royal jelly and seed kernel oil of pinus pumila reg, and its preparing process |
| 02/27/2008 | CN100370987C Tartrate salt of 5,8,14-triazatetracyclo [10,3,1,02,11.04,9]-hexzdeca-2(11),3,5,7,9-pentaene |
| 02/27/2008 | CN100370975C Inhibitors against the production and releaseof inflammator cytokines |
| 02/27/2008 | CN100370906C Method for preparing milk containing composite micron pollen pini and konjak for reducing-weight and lowering-blood sugar |
| 02/26/2008 | US7335799 administering to a patient a hydroxy compound to treat aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic nephropathy, diabetic retinopathy, a disorder of glucose metabolism, dyslipidemia, dyslipoproteinemia, hypertension, impotence, inflammation, septicemia and syndrome X |
| 02/26/2008 | US7335756 Isolated nucleic acid comprising polynucleotide of given sequence; diagnostic kits; use in treatment of cancer |
| 02/26/2008 | US7335723 Melanin-concentrating hormone antagonists |
| 02/26/2008 | US7335689 for example, 6,9-Dihydroxy-2,2,13,13-tetramethyl-tetradecanedioic acid, 2,2,13,13-Tetramethyl-tetradecane-1,6,9,14-tetraol, 6,10-Dihydroxy-2,2,14,14-tetramethyl-pentadecanedioic acid; treatment of Alzheimer's Disease, metabolic syndrome disorder, cancer, cardiovascular disease, diabetic nephropathy |
| 02/26/2008 | US7335687 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, mycoses, gallstones, hyperproliferative disorders, impaired glucose tolerance, or diabetes; aminocyclohexanol derivatives; e.g. N-(4-(4-[ethyl-(2-hydroxy-ethyl)-amino]-but-1-ynyl)-cyclohexyl)-N-methyl-4-trifluoromethyl-benzenesulfonamide |
| 02/26/2008 | US7335681 Inhibit glucosyl ceramide (GlcCer) formation by inhibiting the enzyme GlcCer synthase; Gaucher's disease, Tay Sachs disease, Fabry's disease. Sandhoff disease or GM1 gangliosidosis |
| 02/26/2008 | US7335677 Inhibitors of dipeptidyl peptidase IV |
| 02/26/2008 | US7335676 Methods for treating inflammatory conditions or inhibiting JNK |
| 02/26/2008 | US7335674 Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof |
| 02/26/2008 | US7335671 containing a 2-(hetero)aryloxazol-4-ylalkylcycloalkyl group, (2R/2S)-3-[(1R,3S)-3-(5-methyl-2-m-tolyloxazol-4-ylmethoxymethyl)-cyclohexyloxy ]-2-(4-trifluoromethylbenzyloxy)propionic acid; treatment and/or prevention of disorders of fatty acid metabolism and glucose utilization and insulin resistance; |
| 02/26/2008 | US7335658 Pyridazine derivatives and their use as therapeutic agents |
| 02/26/2008 | US7335655 Treating asthma with e.g. 2-(3-methoxyphenyl)-N-[5-(2,6-dioxo-1,3-dipropyl-2,3,6,9-tetrahydro-1H-purin-8-yl)-1-methyl-1H-pyrazol-3-yl]acetamide; potent, yet selective modulators of adenosine receptors |
| 02/26/2008 | US7335654 Phosphodiesterase 4 inhibitors |
| 02/26/2008 | US7335651 Controlling concentration of cholesterol, leptin, and serotonine in blood; dietetics; adjust fat oxidation |
| 02/26/2008 | US7335646 Compositions and methods for regulated protein expression in gut |
| 02/26/2008 | US7335645 For prophylaxis or treatment of skin or mucosa, autoimmune diseases and inflammation |
| 02/26/2008 | CA2363124C Use of aromatic polycyclic compounds as activators of ppars-type receptors in a cosmetic or pharmaceutical composition |
| 02/26/2008 | CA2238553C Cholesterol-lowering composition |
| 02/21/2008 | WO2008022286A2 Small molecule inhibitors of kynurenine-3-monooxygenase |
| 02/21/2008 | WO2008020799A1 Thienopyrimidin-4-one and thienopyridazin-7-one derivatives as mch rl antagonists |
| 02/21/2008 | WO2008020709A1 Composition and functional food for prevention and treatment of diabetic complications |
| 02/21/2008 | WO2008020625A1 Dibenzoylmethane compound and pharmaceutical composition comprising the compound as active ingredient |
| 02/21/2008 | WO2008020622A1 NOVEL THIENO[2,3-d]PYRIMIDINE COMPOUND |
| 02/21/2008 | WO2008020607A1 Phthalide derivative and salt thereof |
| 02/21/2008 | WO2008020037A1 Use of 2,5-dihydroxybenzene derivatives for treating obesity, hirsutism, hypertricosis and viral warts |
| 02/21/2008 | WO2008019920A1 Processes for production of hoodia plant extracts containing steroidal glycosides |
| 02/21/2008 | WO2008019823A2 Use of certain chemical compounds for the inhibition of the peptidyl-prolyl cis/trans isomerase activity of cyclophilins |
| 02/21/2008 | WO2008019594A1 Agmatine sulfate dihydrate and its medicinal use |
| 02/21/2008 | WO2008006043A3 1,3-oxazole derivatives useful as anti-atherosclerotic, anti-dyslipidemic, anti-diabetic and anti-obesity agents |
| 02/21/2008 | WO2008000951A3 Urea derivatives of tropane, their preparation and their therapeutic application |
| 02/21/2008 | WO2007150026A3 Purinone derivatives as hm74a agonists |
| 02/21/2008 | WO2007149451A3 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
| 02/21/2008 | WO2007146759A3 Novel mch receptor antagonists |
| 02/21/2008 | WO2007136746A3 Macrocyclic compounds and their uses as stearoyl-coa desaturase |
| 02/21/2008 | WO2007127408A3 Methods for treating diabetes |
| 02/21/2008 | WO2007101935A3 Novel heterocyclic cycloalkyl derivatives, method for the preparation thereof, and pharmaceutical compositions containing the same |
| 02/21/2008 | WO2007100822A3 Fluvastatin sodium pharmaceutical compositions |
| 02/21/2008 | WO2007049796A3 Resveratrol and/or grape leaf extract as i. a. endurance improver, anti-aging agent, muscle strength improver |
| 02/21/2008 | WO2006134317A8 Oxadiazole derivatives as dgat inhibitors |
| 02/21/2008 | US20080045709 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors |
| 02/21/2008 | US20080045610 Methods for regulating neurotransmitter systems by inducing counteradaptations |
| 02/21/2008 | US20080045590 Use of substituted cyclopropane acid derivatives for producing drugs for use in the treatment of metabolic syndrome |
| 02/21/2008 | US20080045581 Ppar active compounds |
| 02/21/2008 | US20080045580 Novel Isoxazole Compounds Having Ppar Agonist Activity |
| 02/21/2008 | US20080045573 Methods and Sustained Release Nicotinic Acid Compositions for Treating Hyperlipidemia |
| 02/21/2008 | US20080045567 Therapeutic Agent for Hyperlipemia and Therapeutic Agent for Diabetes |
| 02/21/2008 | US20080045554 hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors; avoiding adverse effects such as hepatotoxicity and cutaneous flushing; low dosage; 2-bromo-8-methyl-4-pentyl-1,4-dihydro-5H-[1,2,4]triazolo[5,1-i]purin-5-one; to treat cardiovascular disorders |
| 02/21/2008 | US20080045550 [1-(4-chloro-3-ethoxy-benzyl)-piperidin-4-yl]-(2-chloro-pyrimidin-4-yl)-amine; somatostatin receptor subtype 5 (SSTR5) antagonists; diabetes mellitus |
| 02/21/2008 | US20080045549 Adenosine a2b receptor antagonists |
| 02/21/2008 | US20080045544 Phenyl, Pyridine, Quinoline, Isoquinoline, Naphthyridine and Pyrazine Derivatives |
| 02/21/2008 | US20080045540 Sulfonyl pyrrolidines, method for producing the same and their use as drugs |
| 02/21/2008 | US20080045527 Immunomodulating Heterocyclic Compounds |
| 02/21/2008 | US20080045524 Selective NPY (Y5) antagonists |
| 02/21/2008 | US20080045510 Succinate salts of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline and crystalline forms thereof |
| 02/21/2008 | US20080045509 Substituted benzyl amine compounds |
| 02/21/2008 | US20080045508 Substituted aminomethyl benzamide compounds |
| 02/21/2008 | US20080045507 Substituted benzamide modulators of the histamine h3 receptor |
| 02/21/2008 | US20080045503 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/21/2008 | US20080045502 Processes for Preparing 3-Benzazepines |
| 02/21/2008 | US20080045483 such as 4-{2-[2-(4-chlorobenzenesulfonylamino)phenyl]ethyl}benzoic acid; hyperglycemic agents |
| 02/21/2008 | US20080045461 N-terminally modified glp-1 receptor modulators |
| 02/21/2008 | US20080045455 RAGE fusion proteins, formulations, and methods of use thereof |
| 02/21/2008 | US20080045447 Fibrilliform-free insulin composition |
| 02/21/2008 | US20080045446 Insulin composition |
| 02/21/2008 | US20080044859 Fibroblast Growth Factor Receptor-Like Molecules and Uses Thereof |
| 02/21/2008 | US20080044500 extract of a plant of the family Liliaceae; Aloe vera; can be safely ingested without causing acute hypoglycemia and has a long-term blood glucose level control action to decrease the hemoglobin Alc level |
| 02/21/2008 | US20080044498 Therapeutic or prophylactic agent, and method of treating or preventing a disease |
| 02/21/2008 | US20080044495 Extract of plant Dendrobii Caulis and preparing process thereof |
| 02/21/2008 | US20080044463 Bradykinin B2 Receptor Antagonist Peptide From Amphibian Skin |
| 02/21/2008 | US20080044425 Polypeptides having phospholipase a2 activity |
| 02/21/2008 | US20080044423 Compounds |
| 02/21/2008 | US20080044419 Treatment of T Cell Mediated Diseases by Inhibition of Fgfr3 |
| 02/21/2008 | US20080044411 Human glp-1 mimetibodies, compositions, methods and uses |
| 02/21/2008 | US20080044410 Immunoglobulin against growth differentiation factor -8 (GDF-8) for use in the prevention and treatment of bone, muscular, nervous system and obesity; muscle enhancement; disorders of insulin metabolism |
| 02/21/2008 | US20080044392 Isolation of Stem Cell-Like Cells and Use Thereof |
| 02/21/2008 | US20080044389 Mortierella schmuckeri microorganisms are cultured in fermentation medium; a polyunsaturated fatty acid for use in food products, nutraceuticals e.g. infant formulas |
| 02/21/2008 | US20080044388 Method for Production of Arachidonic Acid |
| 02/21/2008 | US20080044355 including cystic fibrosis transmembrane conductance regulator ("CFTR"); amido-phenyl derivatives; genetic disorders; respiratory system disorders, cystic fibrosis, hereditary emphysema, hereditary hemochromatosis, coagulation-fibrinolysis and lipid processing deficiencies, lysosomal storage disease |
| 02/21/2008 | CA2660464A1 Processes for production of hoodia plant extracts containing steroidal glycosides |
| 02/21/2008 | CA2658960A1 Phenyl, pyridine and quinoline derivatives |
| 02/20/2008 | EP1889914A1 Compositions for gene therapy of diabetes |
| 02/20/2008 | EP1889911A2 An antisense oligonucleotide preparation method |
| 02/20/2008 | EP1889847A1 Pyrrolopyrimidines for pharmaceutical compositions |
| 02/20/2008 | EP1889842A1 Heterocyclic compound |
| 02/20/2008 | EP1889639A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents |
| 02/20/2008 | EP1889638A1 Medicaments and food for treatment or prevention of obesity and/or diabetes containing cicer arietinum extract |
| 02/20/2008 | EP1889632A1 Remedy for xanthoma |
| 02/20/2008 | EP1889628A1 Lipid liposome composition |
| 02/20/2008 | EP1889622A1 Spiropiperidine compound and medicinal use thereof |
| 02/20/2008 | EP1889618A1 Combined drug for treating diabetes |
| 02/20/2008 | EP1889613A1 Pharmaceutical composition comprising vitamin k |
| 02/20/2008 | EP1889547A2 A food composition and method of using same |